Company Profiles

driven by the PitchBook Platform

Drais Pharmaceuticals

Description

Developer of a drug development platform designed to offer early and mid-stage clinical development. The company's drug development platform addresses unmet medical needs and provides significant benefits over currently available therapies, providing drug development services to virtual companies via vendors and CROs.

2007

Founded

PRIVATE

Status

11-50

Employees

Series A

Latest Deal Type

$20M

Latest Deal Amount

$20M

Total Amount Raised

Description

Developer of a drug development platform designed to offer early and mid-stage clinical development. The company's drug development platform addresses unmet medical needs and provides significant benefits over currently available therapies, providing drug development services to virtual companies via vendors and CROs.

Website:

www.draispharma.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Pharmaceuticals

Other Industries

Drug Discovery

Primary Office

520 US Highway 22 Suite 201 Bridgewater, NJ 08807United States +1 (908) 895-1200
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Drais Pharmaceuticals's full profile, request a free trial.

    Drais Pharmaceuticals Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Drais Pharmaceuticals Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Drais Pharmaceuticals Investors (2)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    InterWest Healthcare PartnersVenture CapitalMinority000 0000000 0000
    Sutter Hill VenturesVenture CapitalMinority000 0000000 0000
    InterWest Healthcare Partners Venture Capital
    Sutter Hill Ventures Venture Capital

    Drais Pharmaceuticals Executive Team (9)

    NameTitleBoard
    Seat
    Contact
    Info
    Stephen Waters Ph.DVice President, Nonclinical & Translational Development and Chief Scientific Officer
    Christine MulhauserDirector
    Deborah HopperDirector, Administration
    Christopher Del MastroDirector, Finance & Contracts
    Rudy LucekExecutive Vice President, Regulatory Affairs and Quality Control
    Stephen Waters Ph.D Vice President, Nonclinical & Translational Development and Chief Scientific Officer
    Christine Mulhauser Director
    Deborah Hopper Director, Administration
    Christopher Del Mastro Director, Finance & Contracts
    Rudy Lucek Executive Vice President, Regulatory Affairs and Quality Control

    Drais Pharmaceuticals Board Members (3)

    NameRepresentingRoleSinceContact
    Info
    Arnold Oronsky Ph.DInterWest PartnersManaging Director000 0000
    Jeffrey Bird Ph.DSutter Hill VenturesManaging Director000 0000
    Robert Desjardins MDDrais PharmaceuticalsBoard Member000 0000
    Arnold Oronsky Ph.D Managing Director InterWest Partners
    Jeffrey Bird Ph.D Managing Director Sutter Hill Ventures
    Robert Desjardins MD Board Member Drais Pharmaceuticals
    Request full access to PitchBook